Compared to other TSX-V COVID stocks, PAS is very cheapMedMira (MIR) and Sona Nanotech (SONA) are both in the very crowded COVID diagnostic space. MIR is currently trading at a $342M valuation, while SONA has a market cap of $459M. Both have delivered tremendous, once-in-a-lifetime returns since the onset of the global pandemic.
PAS, by contrast, is currently worth a paltry $18M even after today's sharp uptick.
Bottom line is that there is still plenty of upside for Pascal Biosciences.